Hospital for Special Surgery

Running trials

• Recruiting

  Safety and Efficacy of ONT01 in Lupus

  NCT07107659· Early phase 1· Hospital for Special Surgery, New York· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

  NCT07176546· Phase 2/3· Robert Spiera, MD· Source

• Recruiting

  AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  NCT07509307· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy

  NCT06893302· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· Phase 2· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Recruiting

  RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

  NCT06455085· University of Alabama at Birmingham· Source

• Active, not recruiting

  Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

  NCT06450886· Phase 2/3· Abcuro, Inc.· Source

• Active, not recruiting

  A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06470048· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

  NCT06559163· Phase 2· Zenas BioPharma (USA), LLC· Source

• Recruiting

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT06290141· Phase 3· Sanofi· Source

• Active, not recruiting

  A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

  NCT06290128· Phase 3· Sanofi· Source

• Enrolling by invitation

  A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

  NCT06518668· Phase 1· Hospital for Special Surgery, New York· Source

• Recruiting

  Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

  NCT05799378· Phase 3· NYU Langone Health· Source

• Recruiting

  Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration

  NCT06423300· ZKR Orthopedics Inc· Source

• Recruiting

  The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

  NCT05538208· Phase 2· Children's Hospital Medical Center, Cincinnati· Source

• Recruiting

  Preventing Injured Knees From osteoArthritis: Severity Outcomes

  NCT06096259· Phase 2· Brigham and Women's Hospital· Source

• Recruiting

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· Phase 2· Scleroderma Research Foundation, Inc.· Source

• Recruiting

  A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

  NCT06072482· Phase 4· Amgen· Source

• Recruiting

  Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

  NCT06311513· Phase 4· Hospital for Special Surgery, New York· Source

• Recruiting

  RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  NCT06154252· Phase 2/3· Cabaletta Bio· Source

• Recruiting

  A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  NCT05895786· Phase 3· Pfizer· Source

• Recruiting

  PRP for Glenohumeral Osteoarthritis

  NCT05675527· Phase 4· Hospital for Special Surgery, New York· Source

• Enrolling by invitation

  G7 Dual Mobility With Vivacit-E or Longevity PMCF

  NCT05548972· Zimmer Biomet· Source

• Recruiting

  Return to Golf After Orthopaedic Surgery

  NCT05675618· Hospital for Special Surgery, New York· Source

• Recruiting

  VIBRANT: VIB4920 for Active Lupus Nephritis

  NCT05201469· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Recruiting

  Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis

  NCT05782335· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

  NCT05126277· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  PRP in ACLR to Prevent PTOA

  NCT05412381· Phase 3· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

  NCT00775476· Phase 2· State University of New York - Upstate Medical University· Source

• Active, not recruiting

  Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

  NCT05270668· Phase 2· Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)· Source

• Active, not recruiting

  Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

  NCT05218668· Phase 2· Woolsey Pharmaceuticals· Source

• Active, not recruiting

  Chronic Pain in Rheumatoid Arthritis

  NCT05038553· Northwestern University· Source

• Active, not recruiting

  Centrally Acting ACE Inhibition in SLE

  NCT04486118· Phase 2· Northwell Health· Source

• Recruiting

  RA-PRO PRAGMATIC TRIAL

  NCT04692493· Phase 3· University of Alabama at Birmingham· Source

• Recruiting

  The KinematX Midcarpal Total Wrist Arthroplasty Registry

  NCT05719935· Extremity Medical· Source

• Active, not recruiting

  INFINITY™ With ADAPTIS™ Technology Study

  NCT04594993· Stryker Trauma and Extremities· Source

• Active, not recruiting

  Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

  NCT04467983· Phase 4· Hospital for Special Surgery, New York· Source

• Recruiting

  Effects of Bisphosphonates on OI-Related Hearing Loss

  NCT04152551· Phase 4· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

  NCT03844061· Phase 2· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)

  NCT04082533· Phase 4· Hospital for Special Surgery, New York· Source

• Active, not recruiting

  JOURNEY II XR Safety and Effectiveness PMCF

  NCT03136887· Smith & Nephew, Inc.· Source

• Active, not recruiting

  A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

  NCT03122522· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

  NCT02682511· Phase 2· Cumberland Pharmaceuticals· Source

• Recruiting

  Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  NCT02418442· Duke University· Source

• Recruiting

  Scleroderma Registry & Repository at the Hospital for Special Surgery

  NCT01656447· Hospital for Special Surgery, New York· Source

• Recruiting

  Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

  NCT00198068· Hospital for Special Surgery, New York· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Osteoarthritis10 recruiting
• Lupus (SLE)6 recruiting
• Rheumatoid arthritis4 recruiting
• Dermatomyositis and polymyositis (myositis)3 recruiting
• Systemic sclerosis (scleroderma)3 recruiting
• ANCA-associated vasculitis2 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Hearing loss1 recruiting
• Obesity1 recruiting
• Osteoporosis1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  Robotic Knee Orthosis-assisted Walking in CP

  NCT06887764· Hospital for Special Surgery, New York· Source

• Recruiting

  Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  NCT06371417· Phase 1· Chugai Pharmaceutical· Source

• Completed

  A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

  NCT06000410· Phase 3· Organogenesis· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

  NCT05721573· Phase 2/3· Abcuro, Inc.· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

  NCT05462522· Phase 1· Genentech, Inc.· Source

• Completed

  Cannabidiol for Bilateral Total Knee Arthroplasty

  NCT04749628· Phase 4· Hospital for Special Surgery, New York· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source

• Terminated

  COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

  NCT05000216· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

  NCT04636229· Phase 3· Organogenesis· Source

• Completed

  Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty

  NCT04075526· Phase 1· NYU Langone Health· Source

• Completed

  Calypso Knee System Clinical Study

  NCT03671213· Moximed· Source

• Completed

  Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

  NCT03675282· Phase 1/2· Weill Medical College of Cornell University· Source

• Completed

  Agili-C™ Implant Performance Evaluation

  NCT03299959· Smith & Nephew, Inc.· Source

• Completed

  Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

  NCT02108860· Phase 3· University of South Florida· Source

• Recruiting

  Simple Bone Cysts in Kids

  NCT02193841· Phase 3· The Hospital for Sick Children· Source

• Terminated

  Consortium of Early Arthritis Cohorts USA

  NCT02386527· Hospital for Special Surgery, New York· Source

• Completed

  A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement

  NCT01969188· Hospital for Special Surgery, New York· Source

• Recruiting

  One-Time DNA Study for Vasculitis

  NCT01241305· University of Pennsylvania· Source

• Completed

  Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

  NCT00597012· Brigham and Women's Hospital· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Osteoarthritis125 works · 19 trials
• Rheumatoid arthritis33 works · 9 trials
• Osteoporosis23 works · 2 trials
• Systemic sclerosis (scleroderma)22 works · 9 trials
• Lupus (SLE)22 works · 12 trials
• ANCA-associated vasculitis3 works · 4 trials
• Essential tremor3 works · 0 trials